BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29270101)

  • 1. Beyond the brotherhood: Skoal Bandits' role in the evolution of marketing moist smokeless tobacco pouches.
    Hendlin YH; Veffer JR; Lewis MJ; Ling PM
    Tob Induc Dis; 2017; 15():46. PubMed ID: 29270101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting Tobacco Use Among Students: The U.S. Smokeless Tobacco Company College Marketing Program.
    Qian ZJ; Hill MJ; Ramamurthi D; Jackler RK
    Laryngoscope; 2021 Jun; 131(6):E1860-E1872. PubMed ID: 33185280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Going Smokeless: Promotional Features and Reach of US Smokeless Tobacco Direct-Mail Advertising (July 2017-August 2018).
    Czaplicki L; Rahman B; Simpson R; Rose SW; Liu M; Perks SN; Moran MB; Schillo BA
    Nicotine Tob Res; 2021 Aug; 23(8):1349-1357. PubMed ID: 33270109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
    Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
    J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining Market Trends in Smokeless Tobacco Sales in the United States: 2011-2019.
    Delnevo CD; Hrywna M; Miller Lo EJ; Wackowski OA
    Nicotine Tob Res; 2021 Aug; 23(8):1420-1424. PubMed ID: 33241271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco-Derived Nicotine Pouch Brands and Marketing Messages on Internet and Traditional Media: Content Analysis.
    Ling PM; Hrywna M; Talbot EM; Lewis MJ
    JMIR Form Res; 2023 Feb; 7():e39146. PubMed ID: 36790840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining market trends in the United States smokeless tobacco use: 2005-2011.
    Delnevo CD; Wackowski OA; Giovenco DP; Manderski MT; Hrywna M; Ling PM
    Tob Control; 2014 Mar; 23(2):107-12. PubMed ID: 23117999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
    Back S; Masser AE; Rutqvist LE; Lindholm J
    BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'No-Barriers' tobacco product? Selling smokeless tobacco to women, people of colour and the LGBTQ+ community in the USA.
    Hendlin YH; Small S; Ling PM
    Tob Control; 2023 May; 32(3):330-337. PubMed ID: 34599083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products.
    Rahman Z; Dharani S; Khuroo T; Khan MA
    AAPS PharmSciTech; 2021 Jan; 22(1):51. PubMed ID: 33459904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is low-nicotine Marlboro snus really snus?
    Foulds J; Furberg H
    Harm Reduct J; 2008 Feb; 5():9. PubMed ID: 18304348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco industry consumer research on smokeless tobacco users and product development.
    Mejia AB; Ling PM
    Am J Public Health; 2010 Jan; 100(1):78-87. PubMed ID: 19910355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and behaviors of snus consumption in Sweden.
    Digard H; Errington G; Richter A; McAdam K
    Nicotine Tob Res; 2009 Oct; 11(10):1175-81. PubMed ID: 19687306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing patterns of tobacco use in a middle-aged population: the role of snus, gender, age, and education.
    Norberg M; Lundqvist G; Nilsson M; Gilljam H; Weinehall L
    Glob Health Action; 2011; 4():. PubMed ID: 21695071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
    Lunell E; Fagerström K; Hughes J; Pendrill R
    Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.
    Alpert HR; Koh H; Connolly GN
    Tob Control; 2008 Oct; 17(5):332-8. PubMed ID: 18669556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
    Richter P; Hodge K; Stanfill S; Zhang L; Watson C
    Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing smokeless tobacco products for smokers: an examination of tobacco industry documents.
    Carpenter CM; Connolly GN; Ayo-Yusuf OA; Wayne GF
    Tob Control; 2009 Feb; 18(1):54-9. PubMed ID: 18948390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
    Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
    Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.